Resultados de la búsqueda 251-260 of 14221 for Keloid scar

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). ... treatment, post-treatment and (when available) post ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

4. Escaras (úlceras por presión)

   Superficial and deep ulcers. In: Treatment of Skin Disease: Comprehensive Therapeutic Strategies. 6th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Studies have shown that cancer patients often feel more comfortable and secure being cared for in their own home environments. SC nivolumab in-home treatment ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... treatment of patients with chronic myelomonocytic leukemia that has come back (recurrent) or that does not respond to treatment (refractory). Onvansertib is ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... treatment, while rates of disease control during Induction have not improved in recent COG trials. The current phase 3 trial seeks to improve the event-free ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... treatment, while rates of disease control during Induction have not improved in recent COG trials. The current phase 3 trial seeks to improve the event-free ...